Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1938 1
1954 1
1959 1
1967 3
1968 1
1973 1
1974 1
1979 1
1987 2
1989 1
1990 3
1991 7
1992 3
1993 6
1994 5
1995 8
1996 10
1997 10
1998 8
1999 10
2000 14
2001 5
2002 5
2003 8
2004 2
2005 8
2006 13
2007 2
2008 2
2009 6
2010 5
2011 4
2012 4
2013 4
2014 4
2015 6
2016 1
2017 7
2018 12
2019 19
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10617749

213 results
Results by year
Filters applied: . Clear all
Page 1
Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, Anderson EL, Steinhoff MC, Edwards KM. Rennels MB, et al. Pediatrics. 2000 Jan;105(1):e12. doi: 10.1542/peds.105.1.e12. Pediatrics. 2000. PMID: 10617749
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
Pichichero ME, Edwards KM, Anderson EL, Rennels MB, Englund JA, Yerg DE, Blackwelder WC, Jansen DL, Meade BD. Pichichero ME, et al. Pediatrics. 2000 Jan;105(1):e11. doi: 10.1542/peds.105.1.e11. Pediatrics. 2000. PMID: 10617748 Clinical Trial.
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. Pichichero ME, et al. Pediatrics. 1997 Nov;100(5):772-88. doi: 10.1542/peds.100.5.772. Pediatrics. 1997. PMID: 9346976 Clinical Trial.
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R, Kuriyakose S, Mesaros N, Han HH, Tomlinson R, Faust SN, Snape MD, Pollard AJ, Finn A. Marlow R, et al. Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22. Vaccine. 2018. PMID: 29576304 Free article. Clinical Trial.
Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines.
Tozzi AE, Anemona A, Stefanelli P, Salmaso S, Ciofi degli Atti ML, Mastrantonio P, Giammanco A; Progetto Pertosse Study Group. Tozzi AE, et al. Pediatrics. 2001 Feb;107(2):E25. doi: 10.1542/peds.107.2.e25. Pediatrics. 2001. PMID: 11158499 Clinical Trial.
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group. Salmaso S, et al. Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81. Pediatrics. 2001. PMID: 11694665 Clinical Trial.
Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).
[No authors listed] [No authors listed] MMWR Recomm Rep. 2000 Nov 17;49(RR-13):1-8. MMWR Recomm Rep. 2000. PMID: 11106289 Free article.
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
McCormack PL. McCormack PL. Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000. Drugs. 2012. PMID: 22931522 Review.
Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan.
Hara M, Okada K, Yamaguchi Y, Uno S, Otsuka Y, Shimanoe C, Nanri H, Horita M, Ozaki I, Nishida Y, Tanaka K. Hara M, et al. Clin Vaccine Immunol. 2013 Dec;20(12):1799-804. doi: 10.1128/CVI.00490-13. Epub 2013 Oct 9. Clin Vaccine Immunol. 2013. PMID: 24108779 Free PMC article. Clinical Trial.
213 results
Jump to page
Feedback